Advertisement

Lasers in Medical Science

, Volume 3, Issue 1–4, pp 93–97 | Cite as

A change in the quantum yield of photoinactivation of cells observed during photodynamic treatment

  • Johan Moan
Article

Abstract

When tumours and cells containing photofrin II (PII) are exposed to light at wavelengths and exposures relevant for photodynamic therapy (PDT), changes in the shape of the prophyrin fluorescence spectra, as well as a decay of the fluorescence intensity, can be observed. These changes are due to (a) photodestruction of porphyrin macrocycles resulting in loss of absorbance and fluorescence; (b) a photoinduced chemical modification of the porphyrins, leaving the porphyrin macrocycle intact; or (c) a photoinduced displacement of the porphyrins to different locations in the cells. The two processes (b) and (c) may lead to changes in the shape of the fluorescence spectra as observed. In this study survival curves were determined for cells grown in vitro, exposed to various concentrations of PII and irradiated with light. It was concluded that the quantum yield for photoinactivation of the cells increased during light exposure under the conditions where changes in the spectral shape of the fluorescence was seen. However, the photodegradation of PII resulted in the need for larger light fluences for cell inactivation at low PII concentrations than could be expected on the basis of a reciprocal dependence between light exposure and applied drug dose.

Key words

Quantum yields Photoinactivation of cells Photosensitization of cells Photodynamic treatment Photofrin II Photodegradation of porphyrins 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Moan J. Effect of bleaching of porphyrin sensitizers during photodynamic therapy.Cancer Lett 1986,33:45–53PubMedCrossRefGoogle Scholar
  2. 2.
    Sandberg S, Brun A. Light-induced protoporphyrin release from erythrocytes in erythropoietic protoporphyria.J Clin Invest 1982,70:693–8PubMedCrossRefGoogle Scholar
  3. 3.
    Rofstad EK, Wahl A, Brustad T. Heat response of human melanoma multicellular spheroids: comparison with single cells and xenografted tumors.Rad Res 1985,102:324–35CrossRefGoogle Scholar
  4. 4.
    Evensen JF, Sommer S, Rimington C, Moan J. Photodynamic therapy of C3H mouse mammary carcinoma with haematoporphyrin di-ethers as sensitizers.Br J. Cancer 1987,55:483–6PubMedGoogle Scholar
  5. 5.
    Moan J, Christensen T, Jacobsen PB. Photodynamic effects on cells in vitro labelled with hematoporphyrin derivative.Photobiochem Photobiophys 1984,7:349–58Google Scholar
  6. 6.
    Mang TS, Dougherty TJ, Potter WR et al. Photobleaching of porphyrins used in photodynamic therapy and implications for therapy.Photochem Photobiol 1987,45:501–6PubMedGoogle Scholar
  7. 7.
    Moan J, Rimington C, Malik C. Photoinduced degradation and modification of photofrin II in cells in vitro.Photochem Photobiol 1988,47:363–8PubMedGoogle Scholar

Copyright information

© Baillière Tindall 1988

Authors and Affiliations

  • Johan Moan
    • 1
  1. 1.Institute for Cancer ResearchOslo 3Norway

Personalised recommendations